Premera Blue Cross Response to COVID-19

  • Premera Blue Cross is here to support members, employers, and healthcare providers during the coronavirus (COVID-19) outbreak.

    Updates as of October 12, 2020

    • See our new section with all COVID-19 related key dates for coverage and benefits listed.
    • Premera is waiving cost shares for all COVID-19 related testing and treatment. Learn more.

    For general questions about COVID-19:
    Washington State Department of Health
    Centers for Disease Control and Prevention

    The Association of Washington Business has an employer resource list you may find helpful.

    If you have health plan questions not covered in these resources, call our customer service team at the number on the back of the member ID card, or your assigned account manager.

    We’ll be updating the following FAQ as additional information is available.

    COVID-19 Key Dates

    COVID-19 Coverage
    See related section for more information about health plan coverage.
    End Date
    Cost share waivers for FDA-approved COVID-19 diagnostic testing other virus/respiratory testing tied to a COVID-19 diagnosis (Federal Families First Act and Washington State OIC mandate) January 21, 2021
    Antibody tests covered only when they are for the purpose of diagnosing a COVID-19 related condition. (CDC and EEOC guidelines) Policy effective July 1, 2020
    Cost share waivers for treatment related to COVID-19 diagnosis is waived through December 31, 2020 (Premera initiative) December 31, 2020
    Medicare Advantage members: cost shares waived for the healthcare provider visit and FDA-authorized COVID-19 diagnostic test for members who meet criteria for testing (CMS guidance) October 23, 2020
    Cost share waivers for telehealth/virtual care visits (Premera initiative) December 31, 2020
    Waiver of prior authorization requirements for home health care or long-term facility services (Washington State OIC mandate) October 14, 2020
    Prescription “refill too soon” override (Premera initiative) November 30, 2020
    30-day premium grace period extended to 60 days for our fully insured groups. Grace period for OptiFlex monthly funding rates and ASC Admin Fee only extended. (Premera initiative) Until further notice
    30-day premium grace period extension to 60 days for our fully insured groups (Premera initiative) December 31, 2020
    For plans with LWAC stop loss, the premium grace period is extended to 60 days from the current filed 31 days in the contract (Premera initiative) Until further notice
    Waive the LOA and Actively at Work requirements for Self-Insured and OptiFlex groups (Premera initiative) January 1, 2021
    Allowance for certain procedures to be handled through Tele-dentistry (Premera initiative) December 31, 2020

    Premera Frequently Asked Questions about COVID-19 and Health Plan Coverage

  • Who is eligible?

    All active insured small and large group employers including associations in Washington state that will be receiving an August 2020 premium bill.

    Do I have to apply? When will I see the premium relief?

    Groups don’t need to apply. We’re working through our internal processes and expect to provide this one-time credit in the group’s August billing cycle.

    How much is being provided?

    Premera is providing up to $25M premium relief through a one-time premium credit estimated to be up to 15%. All eligible groups will receive the same percentage credit.

    Why only fully-insured? Why aren’t self-funded groups included?

    Self-funded groups are at risk for their claims expenses and are seeing a reduction in health plan costs through a reduction in claims and overall utilization.

    Are OptiFlex groups self-funded?

    Yes, OptiFlex are self-funded groups. For these groups, we estimate and bill a flat monthly rate based on projected claims experience with a surplus position calculated at the annual accounting.

    Will this impact producer commissions?

    No; we’re working internally to ensure producer commissions are not impacted.

    Will the premium relief impact rate quotes for renewals?

    No. It will not impact rating decisions. Premera continues to appropriately rate for risk.

    Is this like an MLR rebate?

    It is important to note that this premium credit is not considered a rebate under Affordable Care Act Medical Loss Ratio requirements. However, there may be applicable ERISA requirements that pertain to plan sponsors and appropriate use of plan assets. We suggest consultation with your group’s employment law counsel if you have concerns with any potential ERISA requirements.

    What about individual plans?

    Premera is working to accelerate nearly $40 million in rebates due to Washington customers who purchased their insurance in the individual market due to a requirement under the Affordable Care Act.

    Health insurance carriers participating in the Affordable Care Act are federally required to spend at least 80% of the premiums they collect on health care services, like paying doctors and hospital bills, and efforts to improve health care quality, like improving patient safety. When payers don’t spend at least 80%, it must return funds to individuals. Normally, customers would not see these rebates until late in the year. Premera is working to accelerate distribution of those rebates to later this summer.

    Every business has a different set of circumstances and requirements that should guide their return to work decisions. At Premera, we, too, are evaluating the needs of our business and the needs of our employees as we determine when and how we’ll return to work.

    Here are several resources that other businesses are finding helpful in determining their return to work strategy. We’ll continue to update this list as we come across additional resources.

    1. Interim Guidance from the Centers for Disease Control and Prevention (CDC)

    2. Workplace Decision Tree from the CDC

    3. Wilson Perumal & Co Re-start Playbook

    4. Seattle venture community, the Seattle Metropolitan Chamber of Commerce and the Bellevue Chamber of Commerce Playbook: Reopening the Workplace

    5. Boston Consulting Group: COVID-19 New Normal Planning

    6. State of Washington Safe Start WA

    We encourage employers to monitor local, state, federal guidance and clinical expert organizations such as the CDC, as it pertains to return to work protocols. As new information is available, we’ll share that guidance with you. Premera will continue to be as flexible as possible to provide services to our members and supporting you with the most current and reliable information available.

    Premera isn’t endorsing or sponsoring any of these resources. We thought you might find them useful as you begin planning your own return to work strategy.

    Premera is extending the 30-day premium grace period to 60 days for our fully insured groups. We’ve also implemented a grace period for OptiFlex monthly funding rates, and ASC Admin Fee only. This grace period extension is in effect until further notice.

    This extended grace period is in place to ensure your employees are receiving the care and medications they need during this critical time. Grace period information can be found in your group contract. For those employers who are payroll deducting for the employee part of the premium, we recommend that those payments be remitted timely and not held.

    This is a “premium grace period," not a “claims grace period.” This guards against cancellation. Premera will hold medical, dental and vision claims during the unpaid premium period though members will continue to show as eligible in the system. This will also allow members to get their prescriptions filled.

    During the first 30 days of the grace period, claims will be paid. Claims will then be held beginning day 31 to end of grace period. This applies to claims beginning March 1. During the unpaid premium period, your members will show as eligible in the system. This will also allow members to get their prescriptions filled.

    The extension of the grace period doesn’t eliminate the obligation to pay the premium, but limits policy cancellation for late payment. Grace period information can be found in your group contract.

    To assist with premium payments, we have added a temporary online payment with credit card option for groups. Credit card payments can only be made via the employer portal.  We don’t have the ability to accept credit card payments over the phone. Optiflex groups are excluded from the new credit card payment option as Vimly does not accept credit cards.

    For plans with LWAC Stop loss, LWAC will extend the premium grace period to 60 days from the current filed 31 days in the contract. Delinquency notifications are delivered 30 days prior, stating the bill has to be paid in full at the next cycle.

    There are restrictions that generally do not allow carriers to offer premium discounts or waivers to employers.

    Yes. Recently the Washington State Office of the Insurance Commissioner (OIC) is requiring that insurers notify employees of a delinquent group of the delinquency. If an employer remains unable to pay their premiums for more than 60 days, employees may be required to pay for any unpaid medical bills. These letters will only go to employees of a fully-insured group that is delinquent.

    Yes, in addition to the previous ACH payment option, we have added a temporary online payment with credit card option for groups. Credit card payments can only be made via the employer portal.  We do not have the ability to accept credit card payments over the phone.

    Premera will cover the 2.5% credit card transaction fee.

    Self-funded groups can pay administrative fees through the new credit card payment option, but not claims reimbursements or stop loss premiums.

    Optiflex groups are excluded from the new credit card payment option as Vimly does not accept credit cards.

    The group will need to log into the secure Employer Portal and select billing, then select Pay Online and agree to the online payment Terms and Conditions, add your email address and setup their payment account information. For groups that already have an account set-up, you can manage your funding sources and change to a credit card.

    Our current leave of absence (LOA) allowance for large and small group standard contracts is up to 90 days for furloughed employees and those on leave. For self-insured and OptiFlex groups, we'll allow them to waive the LOA and actively at work requirements. This extension is a Premera initiative.

    No. Premera has made the business decision to not allow a special enrollment period without a standard qualifying event. Marriage, birth, loss of other coverage, and other qualifying events can be found in the plan’s benefit booklets.

    As part of its response to the COVID-19 pandemic, the IRS announced in Notice 2020-29 that it is permitting increased flexibility for mid-year elections during calendar year 2020 for employer-sponsored health coverage, health flexible spending arrangements (FSAs), and dependent care assistance programs (DCAP). While the IRS Notice 20-29 allows additional flexibility, it does not require the health plan to adopt it. Some employees who waived enrollment may be eligible for individual plans on the State or Federal Exchanges. Contact your account manager for information.

    On April 28, 2020, the U.S. Department of Labor's (DOL) Employee Benefits Security

    Administration (EBSA) and the Internal Revenue Service (IRS) issued a rule and guidance, the EBSA Disaster Relief Notice 2020-01, which extends certain health care benefit deadlines.

    The new rule and guidance extend certain health care benefit deadlines under the Employee Retirement Income Security Act (ERISA) and may impact your ConnectYourCare (CYC) programs, including Health Care Flexible Spending Accounts (FSAs), Health Reimbursement Arrangements (HRA), and COBRA.

    Note: Plans not subject to ERISA are not required to comply with this rule, but the government encourages them do to so. Group Plans not subject to ERISA (e.g., church or government plans) and specific types of plans not subject to ERISA (e.g., Dependent Care Assistance Programs (DCAP) and Health Savings Accounts (HSA) or Commuter benefits) are some examples. You should consult your legal and benefits advisors to determine what impact this rule and guidance has on your plans.

    If your plan isn’t subject to ERISA and you wish to opt-out of updating your plan design, contact your Premera Account Manager.

    Premera processes eligibility based on information provided by the employer. As long as the employee remains on the eligibility file, they will remain covered.

    Premera processes eligibility based on information provided by the employer. As long as the employee remains on the eligibility file, they will remain covered.

    We're waiving any re-rating rules for all groups (insured, OptiFlex, and self-funded). Groups who fall under an eligibility threshold will be able to maintain their rates through the end of their plan year.

    Our standard rules remain which allow for reinstatement during the same plan year without experiencing a waiting period or losing their out-of-pocket accumulators. For groups whose plan year ends before June 30, we will treat them as if they were coming back within the same plan year.

    Premera doesn’t have decision making authority on Continuation of Coverage rules. This is state regulated. Anytime someone experiences a job loss, they may be eligible for individual plans on the state or federal exchanges.

    Groups should be aware that individual coverage is available in Washington and employees could meet the Washington Health Insurance Market place special enrollment criteria if they don’t meet eligibility requirements on their group plan.

    On April 29, the U.S. Department of Labor (DOL) announced guidance which extends a number of regulatory deadlines for ERISA plans and plan participants.

    The DOL’s FAQ on health benefit and retirement benefit issues related to COVID-19 are intended to help employee benefit plan participants and beneficiaries, plan sponsors and employers impacted by the COVID-19 outbreak understand their rights and responsibilities under ERISA. Model Notice FAQ.

    Premera processes eligibility based on information provided by the employer. As long as the employee remains on the eligibility file, they will remain covered.

    To support this increasing request, on April 28th we launched new employer website functionality that will show the last 24 months of invoices. Employers will be able to access this on the billing page. This functionality will be permanent.

    The minimum aggregate deductible will be applied as defined in the group’s stop loss contract.

  • Telehealth benefits

  • Premera expanded your telehealth network to give your employees greater access and address the increased demand related to COVID-19. This benefit is a Premera initiative and covers Insured and OptiFlex groups and self-funded groups that have opted in. This is a Premera initiative; see the COVID-19 Key Dates section in this FAQ for current dates.

    Who’s eligible for this benefit?

    This benefit will apply to members of insured groups, individual, grandfathered, non-grandfathered, associations and OptiFlex. Self-funded plans have the option to participate.

    Who's not eligible: Shared admin, FEP, BlueCard, Providence, HCA, Medicare Supplement, Medicare Advantage, and self-funded plans that opt out.

    What’s the cost of these new providers to the member?

    Telehealth cost shares will be waived for all in-network providers. If a telehealth provider charges you a copay, deductible, or coinsurance for telehealth services through December 31, 2020, the provider is responsible for reimbursing the member once the claim is processed and the provider is paid.

    Are brick and mortar in-network offices covered?

    Yes. All in-network providers who offer telehealth options are covered under this expansion.

    When should I use telehealth services and what can they help me with?

    If you’re feeling ill with non-COVID-19 symptoms, you can contact a telehealth provider. Telehealth providers can answer questions, diagnose, and treat acute and chronic illness for non-COVID-19 related symptoms. They can also fulfill necessary prescriptions or order lab tests at local facilities.

    In addition to our existing Premera contracted behavioral health providers (Teladoc BH*, Talkspace, brick and mortar providers and employer assistance programs), we’re introducing new virtual access for behavioral health and substance use disorder treatment (opioid and alcohol): 

    • Doctor On Demand – Doctor on Demand was added to our telehealth network for our March 25 COVID-19 telehealth expansion. These services are available to member adults and children in all states.
    • Boulder Care - Boulder Care is a digital care provider, offering long-term support and medication-based treatment for opioid use disorder (OUD) and common co-occurring conditions for members 18 years and older. Their digital platform allows patients to connect with providers 24/7 through secure video and messaging with clinicians, care advocates, and peer coaches. Boulder Care is working toward 50 states licensure. If they aren’t licensed in a certain state they will transition the member to an in-network provider for the appropriate services.
    • Workit Health – Workit Health is a digital care provider offering support for alcohol use disorder (AUD). Via Workit web and phone apps, members age 18 and older have a “recovery in their pocket” harm reduction and sobriety solution that provides 24/7 access to interactive therapeutic courses, online support groups supervised by licensed care teams. Workit is working toward 50 states licensure. If they aren’t licensed in a certain state, they will transition the member to an in-network provider for the appropriate services.

    Additional covered telehealth services include:

    • Applied behavioral analysis (ABA)
    • Partial hospitalization programs (PHP) for mental health and substance use disorders
    • Intensive outpatient programs (IOP) for mental health and substance use disorders

    *Teladoc behavioral health is currently available only for self-funded groups who previously opted-in to Teladoc behavioral health in addition to their general Teladoc election.

    Effective May 1, 2020, as self-funded groups renew, Teladoc behavioral health will automatically be added for groups that already have general Teladoc services elected. Cost shares would then apply for Teladoc behavioral health through December 31, 2020, depending on whether the group elected to temporarily waive cost shares for telehealth. Teladoc behavioral health will not be added for self-funded groups who do not already have Teladoc services.

    We’ve created a ready-to-share flyer you can share with your customers with more information about these providers.

    Yes. Premera offers Talkspace for all our members. This is an online, virtual behavioral health provider resource. Many local mental health providers are also offering virtual services. Your patient should check with their provider first, or they can go directly to

    Currently, many telehealth providers cannot diagnosis or test for COVID-19 and in many cases, can’t provide a "prescription" for a COVID-19 test. Local providers offering telehealth services, however, may be able to provide a referral to a testing site. Contact your primary care provider for information.

    Yes. Premera-contracted providers are able to provide telehealth services to the extent allowed by their licensure. Members can check with their current provider office to see if they offer telehealth services.

    For Medicare Advantage members: CMS has loosened guidelines around telehealth services during the COVID-19 Public Health Emergency. Starting March 6, 2020, Premera will cover telehealth visits for Medicare Advantage members billed by any healthcare facility at the same cost shares as an in-clinic visit. The previous requirement for services to be provided in certain types of originating sites and locations has been waived for the duration of the COVID-19 Public Health Emergency.

    Yes, this applies to all services where Premera policies and procedures allow for telehealth billing. Please remember that these are all still subject to medical and payment policies.

    We recently modified our medical policies to allow all speech therapy and ABA services to be provided virtually for dates of service on or after 3/20/20 during this emergency period only.

    For groups who did participate in the telehealth expansion and don’t cover telehealth services, these may not apply.

    Yes for certain procedures. Your dentist will be able to code your visit appropriately. This is a temporary modification; see the COVID-19 Key Dates section in this FAQ for current dates.

    The standard allowed amount for telehealth visits is different than for brick and mortar (in office) visits. However, Premera is voluntarily employing CMS guidelines applicable to Medicare to reimburse for telehealth visits with brick and mortar providers at the in-office allowed amount rate.

    Claim costs will be no more than what would have been paid had the member been able to see their providers in person. Premera does not have a specific end date for this approach at this time, but we will continue to monitor CMS Medicare guidelines and the federal emergency period to determine the end date.

    This guidance is in effect for Washington/Alaska group plans, FEP and Individual plans. Shared Admin and all Alaska self-funded groups are excluded from this guidance. Some Washington self-funded groups elected not to participate in this guidance.

    Only claims for telehealth visits from providers who members normally see in-person, in-office will be processed in this manner.

  • Prior authorizations

  • Effective March 25, 2020, the OIC’s second emergency order required we waive or expedite prior authorization requirements for home health care or long-term care facility services. . See the COVID-19 Key Dates section in this FAQ for current dates.

  • COVID-19 benefits and testing

  • The new Families First Coronavirus Response Act requires all group health plans to provide coverage for diagnostic testing, including FDA-approved COVID-19 diagnostic testing products, items, and services related to testing during an office, telehealth, urgent care center or emergency room visit. We have removed the group waivers that were previously in place to comply with this mandate.

    Premera follows state and federal mandates related to end dates for these services. See the COVID-19 Key Dates section in this FAQ for current dates.

    For commercial, Medicare Supplement, and self-funded or OptiFlex groups who opted in: Premera will waive the cost shares for members requiring FDA-approved diagnostic testing for COVID-19. Per the new WA OIC requirements, we’re also waiving in-network copays and deductibles for other virus/respiratory testing tied to a COVID-19 diagnosis. The waivers apply for testing and the related provider visit at in- and out-of-network facilities and laboratories.All other treatments and services including hospitalizations not related to a COVID-19 diagnosis will be subject to the usual benefits and cost shares. We’ll continue to evaluate guidance and the scope of COVID-19 and adjust as needed.

    With the cost of treatment being higher than testing, we wanted to protect our members and have extended the waiver for the higher cost of treatment. See the COVID-19 Key Dates section in this document for current dates.

    For Medicare Advantage members: We’re waiving all cost shares for the healthcare provider visit and FDA-authorized diagnostic COVID-19 testing for members who meet criteria for testing. All other treatments and services including hospitalization are subject to the usual benefits and cost shares.

    Yes, the Families First Act expanded the types of diagnostic COVID-19 lab tests that must be covered by insurance. On April 21, the FDA granted emergency clearance to the first in-home test for COVID-19, a nasal swab kit that will be sold by LabCorp. The test is available to consumers with a doctor’s order in most states.

    FDA-authorized COVID-19 home test kits are only covered when ordered by a licensed physician or pharmacist. Home test kits will not be covered if used for non-diagnostic purposes (e.g. travel, return to work, etc.). Members may submit claims for reimbursement for in-home tests only when they are ordered by a physician or pharmacist. There may also be tax implications for using HSA funds to purchase in-home tests that are used for purposes other than diagnostic.

    Based on the claims we’ve received as of April 7, the average cost for testing is $42, which doesn’t include charges for the associated office or ER visit.

    The IRS issued guidance allowing COVID-19 testing and treatment cost-share waivers for high deductible health plan and non-high deductible health plan members.

    Yes. Drive-through testing for COVID-19 is covered and cost shares will be waived as they are for in-clinic testing.

    Premera will reimburse for antibody tests that are for the purpose of supporting a COVID-19 diagnosis as part of the treatment or management of a patient’s medical condition.  We will not cover antibody tests that are for other purposes, such as back-to-work testing. We believe that this approach meets applicable federal law and regulations governing coverage for COVID-19 testing.

    Premera has developed a Benefit Coverage Guideline that provides basic criteria to confirm that a COVID-19 antibody test has been administered to support the diagnosis of a patient’s disease or condition. The Benefit Coverage Guideline is aligned with current CDC’s guidance on the use of antibody tests in diagnosis of COVID-19. The policy will be in effect for claims with dates of service beginning July 1, 2020.

    As antibody direction has continued to evolve, we’re now at a place where we have solid federal guidance on what is considered medically appropriate under the CARES Act. For dates of service through June 30, 2020, Premera will waive cost shares and cover all antibody test claims. This allows providers adequate time to be notified of our policy.  For dates of service July 1, 2020 and forward, Premera will provide coverage for COVID serology antibody testing only when medically necessary and ordered by practitioner. Premera will not cover testing when used for public health (e.g. contact tracing or surveillance testing) OR when used for return to work. Premera will cover and waive cost shares for antibody testing when used to:

    • Support diagnosis when done in an inpatient setting, or
    • To support diagnosis for persons who present late (9-14 days after illness onset), or
    • Used for persons with complications presumed related to COVID (out-patient), such as multisystem inflammatory syndrome in children.

    Premera has issued a medical policy for serology testing that is consistent with CDC’s current guidance that serology should not be used to determine immune status.

    The FDA has cautioned that these serology tests should not be used as the sole basis to diagnose or exclude COVID-19 infection or to inform infection status.  

    Some lab companies are charging members a $10 non-refundable service fee for “physician oversight services” when a member orders testing directly through a lab. The $10 fee is for an independent physician who orders test for the member. The member also has the option to consult with this physician to discuss their results. This fee is not submitted to insurance for reimbursement by the lab service or the physician. This type of service fee and claim are not covered by the medical plan. To avoid this type of service fee, members should use their own provider or clinic when requesting COVID-19 testing.

    Molecular/antigen testing

    Serology/antibody testing

    The FDA approved two types of tests for diagnosing COVID-19 — molecular and antigen.

    Molecular test: This test detects genetic material of the virus using a lab technique called polymerase chain reaction (PCR). Also called a PCR test.

    Antigen test: This newer COVID-19 test detects certain proteins that are part of the virus. Using a nasal or throat swab to get a fluid sample.

    • Done to determine if person presenting with symptoms has COVID-19.
    • Typically a nasal swab or saliva sample.
    • Covered for diagnostic purposes when ordered by a provider.
    • Both may be offered as a “rapid” test
    • Not covered/not medically necessary for RTW/RTCampus support or other public health purposes.
    • For persons who present 9-14 days after illness onset, serologic testing can be offered in addition to recommended direct detection methods such as polymerase chain reaction.
    • Not medically necessary for diagnosis.
    • Not covered/not medically necessary for RTW/RTCampus support or other public health purposes.

    Yes, this comprehensive approach means that Premera members nationwide will have easier access to medications and testing. These benefits are based on the state the plan was sold in, not where the member resides.

    Additionally, all 36 participating Blue Cross Blue Shield plans across the country are implementing similar approaches to show their collective support.

    Premera recognizes that our members have concern as to whether or not they may have COVID-19. However, it is up to the doctor's determination/evaluation to whether the member meets the criteria for testing/diagnosis based upon guidelines set by the CDC. If the doctor determines the member does not meet the CDC criteria for testing/or workup of possible or diagnosed COVID-19, then cost share waivers will not be applied. Telehealth visits currently have cost shares waived, regardless of diagnosis. We continue to outreach to providers on COVID-19 related billing practices.

    We won't include testing coverage (molecular/antigen or antibody tests) for return-to-work strategies for our insured book of business just as we don’t cover drug testing for employment purposes, as an example. The EEOC has clarified (see A.6) that any mandatory medical test is job related and consistent with business necessity. They have also recommended that employees consent in writing acknowledging that a molecular test done for return to work purposes is not a diagnostic test. Additionally, the CDC said in its Interim Guidelines that antibody test results “should not be used to make decisions about returning persons to the workplace.” The EEOC has stated that because of this, “requiring antibody testing before allowing employees to re-enter the workplace is not allowed under the ADA.” Current versions can’t reliably tell a person that they’re immune, can’t be re-infected or can’t transmit the virus to someone else. Because an immune response takes a while to show up, antibody tests will be negative for those newly infected with COVID-19. The CDC suggest that serologic testing should NOT be used to determine immune status in individuals until the presence, durability, and duration of immunity is established. This includes return to work scenarios.

    We recognize this isn’t an easy situation, and we are in uncharted waters. We will continue to follow the science and do our best to advise and support you whenever possible.

    Premera recognizes how important it is for business to get up and running again. The economic pressure on our customers and our communities is unprecedented. We also believe returning to work as safely as possible, given the circumstances, is even more important.

    Premera will continue to monitor the science and will be ready to launch solutions that feature meaningful testing if and when that becomes available.

    Ultimately, it’s your decision as a self-funded plan sponsor, and if, after considering all this, you are still convinced you want to cover testing, Premera will work with you to administer that charge.

    It’s your decision as a self-funded plan sponsor, and if, after considering all this, you are still convinced you want to install a program that includes testing, Premera may work with you to administer the plan.

    Currently, a vaccine against COVID-19 is not available, but a few COVID-19 vaccines are completing the last stage of development (phase 3 studies).

    Yes, all changes to our insured business apply to Peak Care. MultiCare has also established three respiratory clinics across the region that are by appointment only, as opposed to walk-in visits. They offer COVID-19 testing and additional testing for respiratory issues based on the provider's assessment. Any Peak Care member has additional access to MultiCare’s free e-visits to anyone who has COVID-19 symptoms through their virtual care, where their providers will help them navigate to the next appropriate step, if testing for COVID-19 is warranted. Use promo code “COVID19” at the payment page to unlock the free e-visit after completing their protocol.

    We encourage members to call their providers if they suspect they’ve been exposed to COVID-19 or if they’re experiencing flu-like symptoms. If you do go to the doctor, make sure to call first so they can prepare for your arrival.

    If you have symptoms like a cough, fever, or other respiratory problems, call your doctor first. Do not go to the emergency room. Emergency rooms need to be able to serve those with the most critical needs. If you have difficulty breathing, it doesn't mean you have COVID-19, but you should call 911 if it’s serious.

    24-Hour NurseLine or other telehealth services may be included in your benefits and are also excellent resources if you’re concerned about your symptoms. Many providers offer telehealth services by phone or video chat. Ask your provider if they offer these services.

    Premera is aware of the impact of changes to infection control measures in provider offices and will be covering the separate fee for PPE up to $10 when code D1999 is used on the claim. This is a temporary allowance during the COVID-19 crisis.

    We currently have processes in place to pay government hospitals such as VA facilities and pop-up military hospitals.  We are prepared to process claims if necessary. At this time, we have indicators that these facilities may not bill, but are still working to confirm. Many of these facilities will be covering care not related to COVID-19 to help alleviate the burden on facilities as they care for COVID-19 related patients.

    For members who are out of country: Standard Premera plans don’t cover medical evacuation or repatriation to those overseas who may become ill.

    For members within the U.S.: Plans cover ambulance transport for a medical emergency, when a person’s health is in serious danger and an ambulance is the only safe way to get to the closest medical facility equipped to treat their condition. Emergency transport is subject to the usual benefits and cost shares Transport from a hospital capable of treating the patient because the patient and/or the patient’s family prefer a specific hospital or physician isn’t considered medically necessary.

    Currently, COVID-19 is treatable at many facilities. In the event a patient is transported to one of these facilities under the direction of the Department of Health and Human Services and is otherwise not covered, we'll review the situation to determine eligibility for benefits.

    The CDC recommends that travelers at higher risk for COVID-19 complications avoid all cruise travel and non-essential air travel. We highly recommend that members work with their healthcare provider to come to a care decision that balances risks and expected outcomes with their preferences and values.

    For PDCOE, a key element of that program is to identify and outreach to encourage eligible members to travel to our identified high value specialty care providers. Since travel is a concern and many facilities are cancelling elective procedures, we are temporarily ceasing targeted outreach letters and calls for all lines of business. If a member wants to pursue medical travel, our customer service teams' personal health clinicians are available to help.

    For elective medical travel, we recommend that members work closely with their healthcare providers to determine if travel is recommended and safe. Many hospitals are delaying elective surgeries due to COVID-19, and procedures may be delayed to ensure staff and patient safety. The elective medical travel benefit remains available to members for all approved travel.

    As long as the member is still eligible and has the Blue Cross Blue Shield Global Core program (formerly known as BlueCard Worldwide®) they should be covered outside the United States. Members should look for the suitcase logo on their ID card and can call the number on the back of their card to be connected for services out of the country.

    With Global Core, Premera applies the benefits and coverage determination and approves payment. BCBS Core works with the provider in other countries to set up guarantee of payments. Members must call the number on the back of the card to set up a guarantee of payment.

    You can access proof of coverage from your account. Your online benefit booklet has proof of coverage that can be printed and used for your travel.

  • Pharmacy benefits

  • Yes. We’ve adjusted our “refill too soon” policy for medications. This allows pharmacies to override refill too soon edits during a declared emergency at the pharmacy counter. See the COVID-19 Key Dates section in this FAQ for current dates.

    90-day refills:

    • Most plans have access to mail-order prescriptions. Ask your provider about getting a 90-day supply.
    • Medicare Advantage members: Use this mail-order form.
    • Medicare Supplement members: If you have a separate Part D prescription drug plan, contact your Part D plan administrator for more info.

    Note: Some prescriptions are not eligible for mail order. Check your plan benefits or contact customer service at the number on the back of your member ID card.

    Some telehealth providers have also temporarily waived their refill policies prohibiting the refill of chronic medications beyond twice in a calendar year. Providers will consider clinical appropriateness, patient safety, and professional judgement.

    Currently, controlled substances are not carved out. Pharmacies can override the refill too soon edit at the point of sale by entering a submission code. The dispensing pharmacist will review the need to override refill too soon rejections on controlled substances (such as opioids and benzodiazepines) by working with the prescriber.

    Yes. The Premera pharmacy network maintains rigorous safety standards for inventory and follows guidance from multiple regulatory agencies (including the FDA, CDC, and U.S. Preventive Services Task Force) to ensure drugs are approved by the FDA for the U.S. market. All drugs approved for use in the U.S. must meet FDA-manufacturing standards to assure quality and product label requirements.

    We frequently see drug shortages in the U.S. based on manufacturer issues, raw product issues, etc. We may see new reported shortages based on the COVID-19 impact to Chinese manufacturers. Premera will respond to these shortages the same way we do today, by ensuring the following:

    • The pharmacy team will check public and industry resources to identify new shortages that may impact our members.
    • We’ll review medical policies to determine if adjustments are needed to ensure access to alternative medications (should we change our preferred drugs or update prior authorization criteria to account for shortages both short and long term).
    • Our review processes already account for drug shortages. If a drug we require as first-line therapy is in short supply, we’ll waive this requirement based on market realities and approve coverage when preferred formulary alternatives are in short supply.

    We’re also reviewing rejected claims to see if members are getting the medications they need. If we see any drug shortages, we’ll seek other options to meet member needs. We’ll continue to monitor the situation with our pharmacy partners, so members won’t run out of needed medications.

    Premera has been covering chloroquine and hydroxychloroquine since March, 2020 as they had Emergency Use Authorization from the FDA for COVID treatment. However, on Monday, June 15, the US Food and Drug Administration revoked its emergency authorization of chloroquine and hydroxychloroquine stating they were unlikely to be effective in treating COVID-19. In addition to not helping treat the disease, the drugs were linked to "serious cardiac adverse events and other serious side effects. These drugs still have an indication for other conditions (e.g. lupus, rheumatoid arthritis, malaria) and will continue to be covered for these uses. Quantity limits for new starts on these medications will remain in effect.